Faron Pharmaceuticals Oy (FARN)

Company name:Faron Pharmaceuticals Oy
EPIC:FARNTrading Currency:GBX
Market Sector:AMQ1ISIN:FI4000153309
Market Segment:ASQ1Share Type:DE
WWW Address:http://www.faronpharmaceuticals.com/Description:ORD NPV (DI)
 Price Price Change [%] Bid Ask Open High Low Volume
 332.50 images.advfn.com/imagesnew/2/us/dot 0.0 [0.00] 325.00 340.00 337.50 337.50 332.50 2,790
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 167.77 50.46 0.08 -31.79 - - - 520.00 - 220.00

Faron Pharmaceuticals Oy Key Figures

Key Figures
(at previous day's close)
Market Cap.167.77m
Shares In Issue50.46m
Prev. Close332.50
PE Ratio- 
Dividend Yield-%
EPS - basic-31.79p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-30.86p
Return On Equity (ROE)-%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-19.35%
Dividends PS Growth Rate-%
Net Debt5.44m
Gross Gearing122.10%
Quick Assets6.62m
Net Working Capital0.82m
Intangibles / Fixed Assets98.51%
Turnover PS-p
Pre-Tax Profit PS-29.90p
Retained Profit PS-2.91p
Cash PS7.25p
Net Cash PS-4.23p
Net Tangible Asset Value PS *-4.90p
Net Asset Value PS-3.26p
Spread15.00 (4.41%) 

Faron Pharmaceuticals Oy Balance Sheet

%1$s Balance Sheet

Share Price Performance

Share Price Performance
Sample Period HighLow
1 week337.50321.50
4 weeks370.00321.50
12 weeks387.50310.00
1 year520.00220.00

Share Price Chart (5 years)

Share Price Chart (5 years)

Faron Pharmaceuticals Oy Historic Returns

%1$s Historic Returns
Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week321.5011.003.42321.500.02332.28
4 weeks345.00-12.50-3.62321.500.02336.41
12 weeks387.50-55.00-14.19310.000.02339.84
26 weeks267.5065.0024.30220.000.04340.14
1 year362.50-30.00-8.28220.000.04364.24
3 years152.50180.00118.0351.000.15157.42
5 years257.5075.0029.1351.000.12180.64

Faron Pharmaceuticals Oy Key Management Ratios


Faron Pharmaceuticals Oy Investment Ratios

%1$s Investment Ratios
(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 18.06 
Tobin's Q Ratio (excl. intangibles)20.05 
Dividend Yield-%
Market-to-Book Ratio-101.84 
Price-to-Pre-Tax Profit PS-11.12 
Price-to-Retained Profit PS-114.40 
Price-to-Cash Flow PS-10.77 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS-67.86 
Price-to-Cash PS45.84 
Net Working Capital PS1.63 
Price Pct to Working Capital PS203.80%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Faron Pharmaceuticals Oy Financial Ratios

%1$s Financial Ratios
(Leverage Ratios)
Debt Ratio199.20%
Debt-to-Equity Ratio-2.01 
Debt-to-Equity Ratio (excl. Intgbl)-1.34 
Debt-to-Equity Market Value0.02 
Net Gearing73.00%
Net Gearing (excl. Intangibles)82.09%
Gross Gearing122.10%
Gross Gearing (excl. Intangibles)137.29%
Gearing Under 1 Year77.72%
Gearing Under 1 Year (excl. Intgbl)87.39%
(Liquidity Ratios)
Net Working Capital to Total Assets11.04%
Current Ratio1.14 
Quick Ratio (Acid Test)1.14 
Liquidity Ratio0.63 
Cash & Equiv/Current Assets55.31%
(Solvency Ratios)
Enterprise Value167.42m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.05 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.60 
Total Debt9.10m
Total Debt/Net Current Assets11.06%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-17.12%
5 yr Compound Earnings Growth-1.05%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs3 
Beta coefficients
Beta (60-Mnth)Beta (36-Mnth)

Faron Pharmaceuticals Oy Operating Ratios

%1$s Operating Ratios
(Profitability Ratios)
Return On Capital Employed (ROCE)-908.58%
Return On Assets (ROA)-162.55%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-%
Return On Investment (ROI)-503.43%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debt Collection Period-Days

Faron Pharmaceuticals Oy Dividends

Sorry No Data Available

Faron Pharmaceuticals Oy Fundamentals

Profit and Loss Account
 31 Dec 2017 (EUR)31 Dec 2018 (EUR)31 Dec 2019 (EUR)31 Dec 2020 (EUR)
pre tax profit-21.06--20.08--13.25--16.94-m
attributable profit-21.06--20.09--13.26--16.95-m
retained profit-21.06--20.09--13.26--1.65-m
eps - basic-76.00 -65.00 -31.00 -37.00 
eps - diluted-76.00 -65.00 -31.00 -37.00 
dividends per share- - - - 

Faron Pharmaceuticals Oy Balance Sheet

Balance Sheet
 31 Dec 2017 (EUR)31 Dec 2018 (EUR)31 Dec 2019 (EUR)31 Dec 2020 (EUR)
 31 Dec 2017 (EUR)31 Dec 2018 (EUR)31 Dec 2019 (EUR)31 Dec 2020 (EUR)
fixed assets fixed assets0.020.15%0.020.21%0.010.13%0.010.17%m
intangibles intangibles0.332.18%0.536.56%0.928.96%0.9311.07%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors5.2335.13%3.3942.40%2.2221.77%3.3239.67%m
cash & securities cash & securities9.3162.54%4.0750.82%7.0669.14%4.1149.10%m
creditors - short creditors - short8.0654.11%5.7571.79%6.0859.51%6.5077.72%m
creditors - long creditors - long2.0914.03%1.8923.58%2.5224.72%3.7144.38%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves4.7431.86%0.374.62%1.6115.77%-1.85-22.10%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Faron Pharmaceuticals Oy Cash Flow Statement

%1$s Cash Flow Statement
31 Dec 2017 (EUR)31 Dec 2018 (EUR)31 Dec 2019 (EUR)31 Dec 2020 (EUR)
Operating CF-18.36-20.53-11.52-17.48m
Pre-Financing CF-18.46-20.82-11.62-17.62m
Retained CF-1.88-5.282.99-2.83m

Faron Pharmaceuticals Oy Brokers

Broker infomation is not available for this class of share.
Your Recent History
Faron Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:ca D:20210513 09:17:59